Literature DB >> 7198681

Transsphenoidal microsurgery for prolactin-secreting pituitary adenomas.

M A Faria, G T Tindall.   

Abstract

The authors present the results of transsphenoidal microsurgery in 100 women with the amenorrhea-galactorrhea syndrome caused by pituitary adenomas associated with hyperprolactinemia (prolactinomas). As the surgical results were closely related to the preoperative levels of serum prolactin, the patients were divided into two groups: patients with preoperative prolactin less than 200 ng/ml (Group 1), and those with preoperative prolactin greater than 200 ng/ml (Group 2). The results in Group 1 (72 patients) were significantly better. In this group, 56 (78%) patients regained normal menstrual cycles, and 55 (76%) had return of elevated prolactin to normal following surgery. In Group 2 (28 patients), however, only 11 (39%) resumed normal menstrual periods postoperatively, and 13 (*46%) had return of elevated prolactin levels to normal. There was good correlation between tumor size and the preoperative level of prolactin. Of the 72 women in Group 1, 58 (81%) had tumors less than 1 cm (microadenomas), whereas of the 28 women in Group 2, only four (14%) had tumors of that size. All patients with visual field deficits preoperatively improved or had a normal visual examination postoperatively; none was made worse by surgery. Four patients (three in Group 2) have required additional surgery and/or irradiation. In the last six patients of the series, contrast-enhanced coronal computerized tomography slices made with the updated General Electric scanner detected five microadenomas. Considering that a relatively high percentage of sellar polytomograms are negative in patients with proven microadenomas (that is, only 40 of 72 patients in Group 1 has abnormal polytomography), it is likely that sellar polytomography will significantly decrease in importance in the diagnostic work-up of these patients. The authors provide a rationale for transsphenoidal microsurgery in these patients as opposed to other forms of management, such as bromocriptine therapy and irradiation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7198681     DOI: 10.3171/jns.1982.56.1.0033

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  23 in total

1.  Serial MR intensity changes of the posterior pituitary in patients with diabetes insipidus after transsphenoidal surgery for pituitary adenomas: report of two cases.

Authors:  Koichi Fukino; Shozo Yamada; Takahiro Ohta; Koji Takada; Masaaki Usui
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

2.  Fibrin tissue adhesive sealant for the prevention of CSF leakage following transsphenoidal microsurgery.

Authors:  V Van Velthoven; G Clarici; L M Auer
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

3.  Role of transsphenoidal operation in the management of pituitary adenomas with suprasellar extension.

Authors:  O Bynke; J Hillman
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

4.  Meningitis after transsphenoidal pituitary adenoma removal, but without CSF-fistula.

Authors:  G Hamann; H Bonkhoff; K Schimrigk
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

5.  Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.

Authors:  D Kojo Hamilton; Mary Lee Vance; Paul T Boulos; Edward R Laws
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

6.  Treatment of presumed prolactinoma by transsphenoidal operation: early and late results.

Authors:  J A Thomson; G M Teasdale; D Gordon; D C McCruden; D L Davies
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-30

7.  Enlarged adenomectomy for enclosed prolactinomas: a preliminary study of 26 cases.

Authors:  F Grisoli; T Brue; N Graziani; R Costa; J Trouillas; D Begou; P Jaquet
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

8.  Present status of neurosurgery in the treatment of prolactinomas.

Authors:  R Fahlbusch; M Buchfelder
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

9.  Variations in referral patterns for hypophysectomies among pediatric patients with sellar and parasellar tumors.

Authors:  Debraj Mukherjee; Hasan A Zaidi; Thomas A Kosztowski; Aditya Halthore; George I Jallo; Roberto Salvatori; David C Chang; Alfredo Quiñones-Hinojosa
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

10.  Long term treatment with oral single administration of bromocriptine in patients with hyperprolactinemia.

Authors:  E Ciccarelli; E Mazza; E Ghigo; F Guidoni; A Barberis; F Massara; F Camanni
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.